Article
Study of Fas (CD95) and FasL (CD178) polymorphisms in liver transplant recipients.
Tissue antigens - 1 Feb 2006
Marín L A, Muro M, Moya-Quiles M R, Miras M, Minguela A, Bermejo J, Sanchez-Bueno F, Parrilla P, Alvarez-López M R
Abstract excerpt
The Fas receptor is capable of transducing apoptotic cell death upon interaction with their ligand (FasL). Recent studies suggest that the Fas/FasL system is involved both in graft rejection and in transplantation tolerance. In this study, we analyzed the effect of Fas and FasL polymorphisms in liver allograft outcome. Fas and FasL polymorphisms were analyzed in 151 primary liver graft recipients. The Fas (-670...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
